Protalix Biotherapeutics Inc Share Price

NYSE: PLX

Small Cap

$1.95

+0.04

(+1.83%)

as on September 17, 2025 at 1:29 am IST

$₹

Protalix Biotherapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$1.87
Day's Price Range
$1.96
$1.95
4.10%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
$0.99
52-Week Price Range
$3.1
$1.95
49.23%
Downside
58.97%
Upside

Protalix Biotherapeutics Inc share price movements today

Previous Close: $1.91
Open: $1.90
Volume: 1.2M
Day's Low - High: $1.87 - $1.96
52 Week Low - High: $0.99 - $3.1

Protalix Biotherapeutics Inc Historical Returns

1 Month Return: + 29.05 %
3 Month Return: + 33.57 %
1 Year Return: + 75.23 %
3 Year Return: 0 %
5 Year Return: 0 %

Protalix Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Protalix Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$152.3M

EPS (TTM)

0.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.39%

PE Ratio (TTM)

21.22

Industry PE ratio

P/B Ratio

21.2222

PEG Ratio

-0.1

EBITDA

9.6M

Revenue (TTM)

61.9M

Profit Margin

10.13%

Return On Equity TTM

15.99%

Protalix Biotherapeutics Inc Stock Valuation

Track how Protalix Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Protalix Biotherapeutics Inc in the last 5 years

Overview
Trends

Lowest (29.23x)

June 30, 2025

Industry (0.00x)

September 16, 2025

Today (21.22x)

September 16, 2025

Highest (119.12x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 21.22x

Protalix Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protalix Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Protalix Biotherapeutics Inc	BUY	$152.3M	NA	21.22	10.13%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Protalix Biotherapeutics Inc Stock including INR - Dollar returns

The Protalix Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Protalix Biotherapeutics Inc investment value today

Current value as on today

₹1,83,767

Returns

₹83,767

(+83.77%)

Returns from Protalix Biotherapeutics Inc Stock

₹78,899 (+78.9%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Protalix Biotherapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Protalix Biotherapeutics Inc. Average target price of $14

Protalix Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Protalix Biotherapeutics Inc.

What analysts predicted

86.07%UPSIDE

Target Price

$14

Current Price

$1.95

Analyzed by

5 Analysts

Target

$14.00

Protalix Biotherapeutics Inc target price $14, a slight upside of 86.07% compared to current price of $1.95. According to 5 analysts rating.

Protalix Biotherapeutics Inc Stock's Interest Amongst Investors

Search interest for Protalix Biotherapeutics Inc Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:43% versus previous 30 day period

Protalix Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	9	35	10	10	3	13	17	18	10	15
Gross Profit	6	28	5	1	1	4	9	14	1	9
Operating Income	-2	20	-1	-5	-4	-2	3	7	-4	1
EBITDA	-2	21	0	-5	-4	-1	4	7	-3	1
Interest Expense	0	1	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	19	-1	-6	-4	-2	3	7	-3	0
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-3	19	-1	-6	-4	-2	3	6	-3	0
Net Profit Margin	-32.66%	55.14%	-17.90%	-57.64%	-122.60%	-16.35%	18.02%	35.65%	-35.79%	1.05%

Protalix Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	4	9	21	34	54	62	38	47	65	53
Gross Profit	3	0	5	24	43	52	22	28	42	29
Operating Income	-23	-33	-34	-19	-10	2	-20	-13	10	3
EBITDA	-21	-23	-71	-17	-8	4	-18	-10	12	6
Interest Expense	3	4	9	7	7	9	7	2	3	1
Depreciation	-	-	1	1	1	1	1	1	1	1
Income Before Tax	-27	-29	-83	-26	-18	-6	-27	-14	8	4
Income Tax Expense	-87	10	7	0	7	8	6	0	0	1
Net Income	58	-29	-83	-26	-18	-6	-27	-14	8	2
Net Profit Margin	1329.90%	-319.22%	-395.86%	-77.27%	-33.42%	-10.37%	-71.92%	-31.33%	12.69%	5.49%

Protalix Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	19	-1	-6	-4	-2	3	6	-3	0
Operating Cash Flow	4	-6	3	4	-3	4	3	-5	-5
Investing Cash Flow	0	-20	0	0	0	20	-15	0	0
Financing Cash Flow	10	24	-	-	-	-20	3	5	4
Change in Cash	15	-27	3	3	-3	4	-7	0	-1

Protalix Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-29	-85	-26	-18	-6	-27	-14	8	2
Operating Cash Flow	-32	-9	-7	-19	-26	-10	-25	-1	8
Investing Cash Flow	0	-1	0	0	-19	18	-5	-16	4
Financing Cash Flow	19	-1	-4	46	46	12	8	24	-16
Change in Cash	-13	-12	-13	-20	0	20	-21	6	-3

Insights on Protalix Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.61M → 164.0K (in $), with an average increase of 2306.7% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 10.11M → 15.65M (in $), with an average increase of 35.4% per quarter
POSITIVE IMPACT
Price Rise
In the last 7 days, PLX stock has moved up by 13.0%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PLX has outperformed top 5 stocks with highest market-cap in its industry

About Protalix Biotherapeutics Inc

protalix is a publicly traded, clinical stage biopharmaceutical company (nyse, tase: plx) focused on the development and commercialization of recombinant therapeutic proteins using its proprietary procellex™ plant cell culture protein expression system. procellex provides a unique platform on which we have established a pipeline of proprietary and biosimilar versions of recombinant therapeutic proteins, relying upon known biological mechanisms of action. protalix's lead product, taliglucerase-alfa is an enzyme replacement therapy for the treatment of gaucher´s disease. protalix has concluded phase iii studies for this drug and is currently undergoing fda review. treatment is currently being provided by protalix to gaucher patients under clinical studies and companionate programs to hundreds of patients worldwide. this product has been licensed to pfizer. protalix's pipeline includes multiple therapeutic protein candidates including: acetylcholinesterase (biodefense); alfa‐galactosidase

Organisation	Protalix Biotherapeutics Inc
Headquarters	2 University Plaza, Hackensack, NJ, United States, 07601
Industry	Health Services
CEO	Mr. Dror Bashan
E-voting on shares	Click here to vote

Key Management of Protalix Biotherapeutics Inc

Name	Title
Mr. Dror Bashan	President, CEO & Director
Mr. Yaron Naos B.Sc., MBA	Senior Vice President of Operations
Mr. Eyal Rubin M.B.A.	Executive Officer
Mr. Gilad Mamlok	Senior VP & CFO
Ms. Yael Fellous	Vice President of Human Resources

FAQs

What is Protalix Biotherapeutics Inc share price today?

Protalix Biotherapeutics Inc share price today is $1.95 as on September 17, 2025 at 1:29 am IST at the close of the market. Protalix Biotherapeutics Inc share today touched a day high of $1.96 and a low of $1.87.

What is the 52 week high and 52 week low for Protalix Biotherapeutics Inc share?

Protalix Biotherapeutics Inc share touched a 52 week high of $3.1 on May 1, 2025 and a 52 week low of $0.99 on October 8, 2024. Protalix Biotherapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $1.95,which is 37.10% down from its 52 week high and 96.97% up from its 52 week low.

What is Protalix Biotherapeutics Inc's market capitalisation today?

Protalix Biotherapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Protalix Biotherapeutics Inc Stock (PLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Protalix Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protalix Biotherapeutics Inc Shares that will get you 0.7692 shares as per Protalix Biotherapeutics Inc share price of $1.95 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Protalix Biotherapeutics Inc Stock (PLX) from India?

Indian investors can start investing in Protalix Biotherapeutics Inc (PLX) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 9:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Protalix Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 9:43 am IST). Based on Protalix Biotherapeutics Inc share’s latest price of $1.95 as on September 17, 2025 at 1:29 am IST, you will get 5.1282 shares of Protalix Biotherapeutics Inc. Learn more about fractional shares .